Hosted on MSN3m
FDA approves new pain medicine as opioid alternative. What to know about Journavx
For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to ...
Hosted on MSN31m
Non-Opioid Pain Medication Journavx Gets FDA Approval
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
No Opioids, No Addiction: FDA Approves First New Type of Painkiller in Decades
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
WTTW58m
FDA Approves Painkiller Designed to Eliminate the Risk of Addiction Associated With Opioids
It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids ...
Live Science1h
FDA approves 1st new class of opioid-free painkillers in over 20 years
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
KAAL TV1h
Sen. Grassley helps introduce bill to prevent youth opioid abuse
Senate Judiciary Chairman Chuck Grassley of Iowa announced on Friday the introduction of a bill aimed at preventing opioid ...
Kennedy Says He Will Give HPV Vaccine Lawsuit Proceeds to His Son
Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that ...
aha.org1h
FDA approves first-in-class non-opioid painkiller
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
FDA approved the first new kind of pain medication in 27 years. Here’s how it works
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
Healio2h
FDA approves nonopioid Journavx for moderate to severe acute pain
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
AARP3h
Newly Approved Painkiller Provides Relief Without Addiction
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental There’s a new way for doctors to treat the ...